NewsRx

Search our medical news database

Treatment - HAV

"Antiviral Substances Active In Vitro on Multiplication of Hepatitis A Virus."

Published in Cancer Weekly, July 10th, 1995

According to an abstract submitted by the authors to The Year of Louis Pasteur International Symposia entitled Etiology and Pathogenesis of Infectious Diseases, held April 10-13, 1995, in Dakar, Senegal, "The Hepatitis A Virus (HAV) is still of great epidemiological importance even though the use of an efficient vaccine should control it in the long run. A decrease in the circulation of this virus has led to the appearance of delayed contamination in unprotected populations accompanied by serious clinical forms. The objective of the study of antiviral substances is to arrive at the definition of protocols which could be used in therapy. The antiviral effect of different substances was...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook